✦ LIBER ✦

The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer

✍ Scribed by Torben Frøstrup Hansen; Flemming Brandt Sørensen; Jan Lindebjerg; Anders Jakobsen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biweekly XELOX (capecitabine and oxalipl

✍ Grande, Carlos; Quintero, Guillermo; Candamio, Sonia; París Bouzas, Lorena; Vill 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 337 KB

Capecitabine and bevacizumab as first-li

✍ Feliu, J; Safont, M J; Salud, A; Losa, F; García-Girón, C; Bosch, C; Escudero, P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB

Reply: Capecitabine and bevacizumab as f

✍ Feliu, J; Barriuso, J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 69 KB

Phase II study of capecitabine plus oxal

✍ Yu Hong Li; Hui Yan Luo; Feng Hua Wang; Zhi Qiang Wang; Miao Zhen Qiu; Yan Xia S 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 234 KB

Capecitabine plus oxaliplatin (xelox) in

✍ Emel Yaman; Aytug Uner; Ozlem Er; Ugur Coskun; Suleyman Buyukberber; Mustafa Dik 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 140 KB

Comment on ‘Capecitabine and bevacizumab

✍ Molina-Garrido, M J; Guillén-Ponce, C 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB